to assess the value of serum neuron-specific enolase ( s-nse ) as a possible marker of sclc , the serum levels of 81 patients with sclc ( 59 patients with extensive disease and 22 patients with limited disease ) were compared with the serum levels of patients with non-small cell lung cancer ( n-sclc ) and 93 patients with nonmalignant lung diseases .
C0007131
non-small cell lung cancer
C0024109
lung